{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:08:27Z","timestamp":1779210507332,"version":"3.51.4"},"reference-count":33,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Introduction: Cervical cancer is among the most frequent types of neoplasia worldwide and remains the fourth leading cause of cancer death in women, a fact that raises the necessity for further development of therapeutic strategies. NCCN guidelines recommend radiation therapy with or without chemotherapy as the gold standard for locally advanced cervical cancer. Also, some studies claim that performing surgery after chemo-radiation therapy does not necessarily improve the therapeutic outcome. This study aims to determine the impact of the risk factors, various characteristics, and surgical treatment for patients in different stages of the disease on survival rate. Material and methods: Our study started as a retrospective, observational, unicentric one, carried out on a cohort of 96 patients diagnosed with cervical cancer from the surgical department of the Bucharest Oncological Institute, followed from 1 January 2019 for a period of 3 years. After the registration of the initial parameters, however, the study became prospective, as the patients were closely monitored through periodical check-ups. The end-point of the study is either the death of the participants or reaching the end of the follow-up period, and, therefore, we divided the cohort into two subgroups: the ones who survived after three years and the ones who did not. All 96 patients, with disease stages ranging from IA2 to IIIB, underwent radio-chemotherapy followed by adjuvant surgery. Results: Among the 96 patients, 45 (46%) presented residual tumor after radio-chemotherapy. Five patients (5%) presented positive resection margins at the post-operative histopathological examination. The presence of residual tumor, the FIGO stage post-radiotherapy, positive resection margins, and lympho-vascular and stromal invasions differed significantly between the subgroups, being more represented in the subgroup that reached the end-point. Variables correlated with the worst survival in Kaplan\u2013Meier were the pelvic lymph node involvement\u201450% at three years (p\u20140.015)\u2014and the positive resection margins\u2014only 20% at three years (p &lt; 0.001). The univariate Cox model identified as mortality-associated risk factors the same parameters as above, but also the intraoperative stage III FIGO (p &lt; 0.001; HR 9.412; CI: 2.713 to 32.648) and the presence of post-radiotherapy adenopathy (p\u20140.031; HR: 3.915; CI: 1.136 to 13.487) identified through imagistic methods. The independent predictors of the overall survival rate identified were the positive resection margins (p\u20140.002; HR: 6.646; CI 2.0 to 22.084) and the post-radiotherapy stage III FIGO (p\u20140.003; HR: 13.886; CI: 2.456 to 78.506). Conclusions: The most important predictor factors of survival rate are the positive resection margins and the FIGO stage after radiotherapy. According to the NCCN guidelines in stages considered advanced (beyond stages IB3, IIA2), the standard treatment is neoadjuvant chemoradiotherapy. In our study, with radical surgery after neoadjuvant therapy, 46% of patients presented residual tumor at the intraoperative histopathological examination, a fact that makes the surgical intervention an important step in completing the treatment of these patients. In addition, based on the patient\u2019s features\/comorbidities and the clinical response to chemotherapy\/radiotherapy, surgeons could carefully tailor the extent of radical surgery, thus resulting in a personalized surgical approach for each patient. However, a potential limitation can be represented by the relatively small number of patients (96) and the unicentric nature of our study.<\/jats:p>","DOI":"10.3390\/medicina59122147","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T06:56:00Z","timestamp":1702277760000},"page":"2147","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer"],"prefix":"10.3390","volume":"59","author":[{"given":"Irinel-Gabriel","family":"Dicu-Andreescu","sequence":"first","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian-Augustin","family":"Marinca\u0219","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-053X","authenticated-orcid":false,"given":"Virgiliu-Mihail","family":"Prunoiu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-5803","authenticated-orcid":false,"given":"Ioana","family":"Dicu-Andreescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00eenziana-Octavia","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-0199","authenticated-orcid":false,"given":"Anca-Angela","family":"Simionescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Br\u0103tucu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren\u021biu","family":"Simion","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle-income countries (Review)","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mekonnen, A.G., and Mittiku, Y.M. (2023). Early-onset of sexual activity as a potential risk of cervical cancer in Africa: A review of literature. PLOS Glob. Public Health, 3.","DOI":"10.1371\/journal.pgph.0000941"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113371","DOI":"10.1016\/j.envres.2022.113371","article-title":"Association between involuntary smoking and risk of cervical cancer in Chinese female never smokers: A prospective cohort study","volume":"212","author":"Wen","year":"2022","journal-title":"Environ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/hiv.13490","article-title":"The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model","volume":"24","author":"Gilles","year":"2023","journal-title":"HIV Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijgo.13870","article-title":"Obesity and gynecological cancers: A toxic relationship","volume":"155","author":"Wichmann","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2020.02.014","article-title":"Oral contraceptives use and risk of cervical cancer\u2014A systematic review & meta-analysis","volume":"247","author":"Asthana","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_10","first-page":"e21331","article-title":"The Role of Chlamydia Trachomatis in the Pathogenesis of Cervical Cancer","volume":"14","author":"Iskander","year":"2022","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Todor, R.D., Bratucu, G., Moga, M.A., Candrea, A.N., Marceanu, L.G., and Anastasiu, C.V. (2021). Challenges in the Prevention of Cervical Cancer in Romania. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18041721"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2013Update 2023*","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_13","unstructured":"(2023, November 04). Prof. Dr. Viorica Nagy [1 2], Conf. Dr. Alin Rancea [1, 2], Dr. Ovidiu Coza [1, 2], Dr. Gabriel Kacso [1, 2], Dr. Br\u00e2ndu\u015fa Aldea, Dr. Alexandru Eniu. Ghid MS Conduita Cancer Col Uterin n.d. Available online: http:\/\/old.ms.ro\/index.php?pag=181&pg=5."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, H.-H., Meng, W.-Y., Li, R.-Z., Wang, Q.-Y., Wang, Y.-W., Pan, H.-D., Yan, P.-Y., Wu, Q.-B., Liu, L., and Yao, X.-J. (2021). Potential prognostic factors in progression-free survival for patients with cervical cancer. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08243-3"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/etm.2020.9525","article-title":"Impact of histological subtype on the response to chemoradiation in locally advanced cervical cancer and the possible role of surgery","volume":"21","author":"Voinea","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_16","first-page":"1","article-title":"Adjuvant Hysterectomy in Patients with Residual Disease after Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study","volume":"5","author":"Pervin","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajog.2004.05.076","article-title":"Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: Complications and survival rates","volume":"191","author":"Decker","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.2147\/CMAR.S203059","article-title":"Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors","volume":"11","author":"Yan","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/ijmr.IJMR_4225_20","article-title":"Implications of the revised cervical cancer FIGO staging system","volume":"154","author":"Bhatla","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"934110","DOI":"10.3389\/fonc.2022.934110","article-title":"The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gil-Iba\u00f1ez, B., Gil-Moreno, A., Torn\u00e9, A., Mart\u00edn Jimenez, A., Gorostidi, M., Zapardiel, I., Garcia, A.T., Diaz-Feijoo, B., and SEGO Spain-GOG Cervical Cancer Task Forc\u00e9 (2022). Tumor Size and Oncological Outcomes in Patients with Early Cervical Cancer Treated by Fertility Preservation Surgery: A Multicenter Retrospective Cohort Study. Cancers, 14.","DOI":"10.3390\/cancers14092108"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3802\/jgo.2019.30.e40","article-title":"Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri","volume":"30","author":"Berek","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjc.6605801","article-title":"The impact of lymph node density on survival of cervical cancer patients","volume":"103","author":"Polterauer","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.suronc.2016.05.028","article-title":"Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma\/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study","volume":"25","author":"Twu","year":"2016","journal-title":"Surg. Oncol."},{"key":"ref_25","unstructured":"(2023, August 17). Cervical Cancer: Statistics. Available online: https:\/\/www.cancer.net\/cancer-types\/cervical-cancer\/statistics."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clinthera.2016.01.024","article-title":"Cervical Cancer in Women Aged 35 Years and Younger","volume":"38","author":"Pelkofski","year":"2016","journal-title":"Clin. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2016.04.248","article-title":"Surgical resection margin including parametrium and vagina significantly correlates with survival of FIGO stage IB cervical cancer patients treated with radical hysterectomy: Multivariate analysis of 360 patients","volume":"141","author":"Kong","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Stanca, M., and C\u0103p\u00eelna, M.E. (2021). Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030570"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Broberg, G., Wang, J., \u00d6stberg, A.-L., Adolfsson, A., Nemes, S., Spar\u00e9n, P., and Strander, B. (2018). Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190171"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Furtunescu, F., Bohiltea, R.E., Neacsu, A., Grigoriu, C., Pop, C.S., Bacalbasa, N., Ducu, I., Iordache, A.-M., and Costea, R.V. (2021). Cervical Cancer Mortality in Romania: Trends, Regional and Rural\u2013Urban Inequalities, and Policy Implications. Medicina, 58.","DOI":"10.3390\/medicina58010018"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1245\/s10434-020-09302-y","article-title":"Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis","volume":"28","author":"Ferrandina","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jmig.2016.09.005","article-title":"Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study","volume":"24","author":"Gallotta","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2015.04.035","article-title":"Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies","volume":"138","author":"Legge","year":"2015","journal-title":"Gynecol. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/12\/2147\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:30Z","timestamp":1760132190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/12\/2147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["medicina59122147"],"URL":"https:\/\/doi.org\/10.3390\/medicina59122147","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]}}}